1. Home
  2. CVGI vs TLSA Comparison

CVGI vs TLSA Comparison

Compare CVGI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$4.51

Market Cap

167.7M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.30

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
TLSA
Founded
2000
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.7M
155.3M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
CVGI
TLSA
Price
$4.51
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
657.7K
179.7K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
N/A
EPS
0.04
N/A
Revenue
$755,231,000.00
N/A
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$110.00
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.29
$1.04
52 Week High
$5.88
$2.60

Technical Indicators

Market Signals
Indicator
CVGI
TLSA
Relative Strength Index (RSI) 41.13 56.52
Support Level $3.73 $1.26
Resistance Level $4.45 $1.44
Average True Range (ATR) 0.40 0.09
MACD -0.07 0.02
Stochastic Oscillator 8.15 96.43

Price Performance

Historical Comparison
CVGI
TLSA

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: